Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1981 1
1985 1
1986 1
1988 2
1989 4
1990 5
1991 3
1992 3
1993 3
1996 1
1998 1
1999 1
2000 2
2002 1
2003 3
2004 3
2005 2
2006 3
2007 6
2008 7
2009 6
2010 4
2011 7
2012 5
2013 6
2014 4
2015 6
2016 5
2017 1
2018 5
2019 3
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

100 results
Results by year
Filters applied: . Clear all
Page 1
The cellular basis of protease-activated receptor 2-evoked mechanical and affective pain.
Hassler SN, Kume M, Mwirigi JM, Ahmad A, Shiers S, Wangzhou A, Ray PR, Belugin SN, Naik DK, Burton MD, Vagner J, Boitano S, Akopian AN, Dussor G, Price TJ. Hassler SN, et al. Among authors: vagner j. JCI Insight. 2020 Jun 4;5(11):e137393. doi: 10.1172/jci.insight.137393. JCI Insight. 2020. PMID: 32352932 Free PMC article.
Hitting multiple targets with multimeric ligands.
Handl HL, Vagner J, Han H, Mash E, Hruby VJ, Gillies RJ. Handl HL, et al. Among authors: vagner j. Expert Opin Ther Targets. 2004 Dec;8(6):565-86. doi: 10.1517/14728222.8.6.565. Expert Opin Ther Targets. 2004. PMID: 15584863 Review.
Peptidomimetics, a synthetic tool of drug discovery.
Vagner J, Qu H, Hruby VJ. Vagner J, et al. Curr Opin Chem Biol. 2008 Jun;12(3):292-6. doi: 10.1016/j.cbpa.2008.03.009. Epub 2008 May 14. Curr Opin Chem Biol. 2008. PMID: 18423417 Free PMC article. Review.
Cell-specific targeting by heterobivalent ligands.
Josan JS, Handl HL, Sankaranarayanan R, Xu L, Lynch RM, Vagner J, Mash EA, Hruby VJ, Gillies RJ. Josan JS, et al. Among authors: vagner j. Bioconjug Chem. 2011 Jul 20;22(7):1270-8. doi: 10.1021/bc1004284. Epub 2011 Jun 16. Bioconjug Chem. 2011. PMID: 21639139 Free PMC article.
Hetero-bivalent GLP-1/glibenclamide for targeting pancreatic β-cells.
Hart NJ, Chung WJ, Weber C, Ananthakrishnan K, Anderson M, Patek R, Zhang Z, Limesand SW, Vagner J, Lynch RM. Hart NJ, et al. Among authors: vagner j. Chembiochem. 2014 Jan 3;15(1):135-45. doi: 10.1002/cbic.201300375. Epub 2013 Nov 20. Chembiochem. 2014. PMID: 24259278 Free PMC article.
Rigid linkers for bioactive peptides.
Vagner J, Handl HL, Monguchi Y, Jana U, Begay LJ, Mash EA, Hruby VJ, Gillies RJ. Vagner J, et al. Bioconjug Chem. 2006 Nov-Dec;17(6):1545-50. doi: 10.1021/bc060154p. Bioconjug Chem. 2006. PMID: 17105235 Free PMC article.
Enhanced targeting with heterobivalent ligands.
Xu L, Vagner J, Josan J, Lynch RM, Morse DL, Baggett B, Han H, Mash EA, Hruby VJ, Gillies RJ. Xu L, et al. Among authors: vagner j. Mol Cancer Ther. 2009 Aug;8(8):2356-65. doi: 10.1158/1535-7163.MCT-08-1183. Epub 2009 Aug 11. Mol Cancer Ther. 2009. PMID: 19671749 Free PMC article.
Squalene-derived flexible linkers for bioactive peptides.
Jagadish B, Sankaranarayanan R, Xu L, Richards R, Vagner J, Hruby VJ, Gillies RJ, Mash EA. Jagadish B, et al. Among authors: vagner j. Bioorg Med Chem Lett. 2007 Jun 15;17(12):3310-3. doi: 10.1016/j.bmcl.2007.04.001. Epub 2007 Apr 6. Bioorg Med Chem Lett. 2007. PMID: 17448660 Free PMC article.
100 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page